IMNM

IMNM

USD

Immunome Inc. Common Stock

$15.410-0.950 (-5.807%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$16.360

Hoch

$16.800

Tief

$15.060

Volumen

0.74M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.3B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.31M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $5.15Aktuell $15.410Hoch $17.87

Ähnliche Nachrichten

BusinessWire

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the "company") (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Nov. 3, 2025, the Compensation Committee of

Mehr anzeigen
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BusinessWire

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim

Mehr anzeigen
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
BusinessWire

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, recently presented preclinical data showing its proprietary antibody-drug conjugate

Mehr anzeigen
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance